[1]
Cai, Z.; Yang, Y.; Zhang, J. Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): A meta-analysis. BMC Public Health, 2021, 21(1), 1505.
[http://dx.doi.org/10.1186/s12889-021-11546-6] [PMID: 34348687]
[http://dx.doi.org/10.1186/s12889-021-11546-6] [PMID: 34348687]
[2]
Fuster, J.J.; Ouchi, N.; Gokce, N.; Walsh, K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ. Res., 2016, 118(11), 1786-1807.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306885] [PMID: 27230642]
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306885] [PMID: 27230642]
[3]
Messina, G.; Polito, R.; Monda, V. Functional role of dietary intervention to improve the outcome of COVID-19: A hypothesis of work. Int. J. Mol. Sci., 2020, 21(9), 3104.
[http://dx.doi.org/10.3390/ijms21093104] [PMID: 32354030]
[http://dx.doi.org/10.3390/ijms21093104] [PMID: 32354030]
[4]
Salvator, H.; Grassin-Delyle, S.; Naline, E. Contrasting effects of Adipokines on the cytokine production by primary human bronchial epithelial cells: Inhibitory effects of adiponectin. Front. Pharmacol., 2020, 11, 56.
[http://dx.doi.org/10.3389/fphar.2020.00056] [PMID: 32132922]
[http://dx.doi.org/10.3389/fphar.2020.00056] [PMID: 32132922]
[5]
Assad, N.A.; Sood, A. Leptin, adiponectin and pulmonary diseases. Biochimie, 2012, 94(10), 2180-2189.
[http://dx.doi.org/10.1016/j.biochi.2012.03.006] [PMID: 22445899]
[http://dx.doi.org/10.1016/j.biochi.2012.03.006] [PMID: 22445899]
[6]
Dallinga-Thie, G.M.; Dullaart, R.P. Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations? Atherosclerosis, 2010, 208(2), 328-329.
[http://dx.doi.org/10.1016/j.atherosclerosis.2009.12.014] [PMID: 20053404]
[http://dx.doi.org/10.1016/j.atherosclerosis.2009.12.014] [PMID: 20053404]
[7]
Gómez-Ambrosi, J.; Salvador, J.; Silva, C. Increased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin. Thromb. Haemost., 2006, 95(6), 991-996.
[http://dx.doi.org/10.1160/TH06-02-0079] [PMID: 16732378]
[http://dx.doi.org/10.1160/TH06-02-0079] [PMID: 16732378]
[8]
Luzi, L.; Radaelli, M.G. Influenza and obesity: Its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol., 2020, 57(6), 759-764.
[http://dx.doi.org/10.1007/s00592-020-01522-8] [PMID: 32249357]
[http://dx.doi.org/10.1007/s00592-020-01522-8] [PMID: 32249357]
[9]
Kassir, R. Risk of COVID-19 for patients with obesity. Obes. Rev., 2020, 21(6), e13034.
[http://dx.doi.org/10.1111/obr.13034] [PMID: 32281287]
[http://dx.doi.org/10.1111/obr.13034] [PMID: 32281287]
[10]
Bergantin, L.B. Debating the “bidirectional link” between diabetes and depression through the Ca2+/cAMP signalling: Off-label effects of Ca2+ channel blockers. Pharmacol. Res., 2019, 141, 298-302.
[http://dx.doi.org/10.1016/j.phrs.2019.01.008] [PMID: 30639385]
[http://dx.doi.org/10.1016/j.phrs.2019.01.008] [PMID: 30639385]
[11]
Arruda, A.P.; Hotamisligil, G.S. Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes. Cell Metab., 2015, 22(3), 381-397.
[http://dx.doi.org/10.1016/j.cmet.2015.06.010] [PMID: 26190652]
[http://dx.doi.org/10.1016/j.cmet.2015.06.010] [PMID: 26190652]
[12]
Bergantin, L.B. The clinical link between depression and obesity: Role of Ca2+/cAMP signalling. Psychiatry Res., 2020, 291, 113167.
[http://dx.doi.org/10.1016/j.psychres.2020.113167] [PMID: 32562933]
[http://dx.doi.org/10.1016/j.psychres.2020.113167] [PMID: 32562933]
[13]
Bergantin, L.B. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3′-5′-cyclic adenosine monophosphate signaling. World J. Diabetes, 2021, 12(6), 767-779.
[http://dx.doi.org/10.4239/wjd.v12.i6.767] [PMID: 34168726]
[http://dx.doi.org/10.4239/wjd.v12.i6.767] [PMID: 34168726]
[14]
Bergantin, L.B. The interplay among epilepsy, Parkinson’s Disease and inflammation: Revisiting the link through Ca2+/cAMP signalling. Curr. Neurovasc. Res., 2021, 18(1), 162-168.
[http://dx.doi.org/10.2174/1567202618666210603123345] [PMID: 34082680]
[http://dx.doi.org/10.2174/1567202618666210603123345] [PMID: 34082680]
[15]
Park, H.W.; Lee, J.H. Calcium channel blockers as potential therapeutics for obesity-associated autophagy defects and fatty liver pathologies. Autophagy, 2014, 10(12), 2385-2386.
[http://dx.doi.org/10.4161/15548627.2014.984268] [PMID: 25484079]
[http://dx.doi.org/10.4161/15548627.2014.984268] [PMID: 25484079]
[16]
Olivier, M. Modulation of host cell intracellular Ca2+. Parasitol. Today, 1996, 12(4), 145-150.
[http://dx.doi.org/10.1016/0169-4758(96)10006-5] [PMID: 15275223]
[http://dx.doi.org/10.1016/0169-4758(96)10006-5] [PMID: 15275223]
[17]
Scherbik, S.V.; Brinton, M.A. Virus-induced Ca2+ influx extends survival of west nile virus-infected cells. J. Virol., 2010, 84(17), 8721-8731.
[http://dx.doi.org/10.1128/JVI.00144-10] [PMID: 20538858]
[http://dx.doi.org/10.1128/JVI.00144-10] [PMID: 20538858]
[18]
Dionicio, C.L.; Peña, F.; Constantino-Jonapa, L.A. Dengue virus induced changes in Ca2+ homeostasis in human hepatic cells that favor the viral replicative cycle. Virus Res., 2018, 245, 17-28.
[http://dx.doi.org/10.1016/j.virusres.2017.11.029] [PMID: 29269104]
[http://dx.doi.org/10.1016/j.virusres.2017.11.029] [PMID: 29269104]
[19]
Nugent, K.M.; Shanley, J.D. Verapamil inhibits influenza A virus replication. Arch. Virol., 1984, 81(1-2), 163-170.
[http://dx.doi.org/10.1007/BF01309305] [PMID: 6743023]
[http://dx.doi.org/10.1007/BF01309305] [PMID: 6743023]
[20]
Johansen, L.M.; DeWald, L.E.; Shoemaker, C.J. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med., 2015, 7(290), 290ra89.
[http://dx.doi.org/10.1126/scitranslmed.aaa5597] [PMID: 26041706]
[http://dx.doi.org/10.1126/scitranslmed.aaa5597] [PMID: 26041706]
[21]
Martin, I.J. COVID-19 infection and anti-aging gene inactivation. Acta Scientific Nutritional Health, 2020, 4(5), 1-2.